What was once a niche benefit only offered by tech and financial service companies has expanded to industries of all sizes.

A woman who endured fertility issues after being exposed to a drug linked to a rare cancer while in her mother’s womb has ...

Michelle Taylor said she feared the issues linked with exposure to diethylstilbestrol had also impacted her daughter.

Campaigners say IVF treatment should be less stigmatised in the workplace and come with legal entitlements to time off ...

Survivor Michelle Taylor says women given diethylstilbestrol (DES) were ‘like lambs to the slaughter’ as hundreds of victims ...

DES was prescribed from 1940 to the 1970s to prevent miscarriage, premature labour and pregnancy complications ...

Successful completion of first trial phase enables continued pivotal trial of FemBloc, the only non-surgical permanent birth ...

Woman exposed to cancer-linked drug in womb feared she could never have children - The teacher stated was never informed that ...

How do stem cells know what to become? Nearly three decades after scientists isolated the first human embryonic stem cells, researchers are still working hard to understand precisely how a single, ...

Successful completion of first trial phase enables continued pivotal trial of FemBloc, the only non-surgical permanent birth control, toward U.S. FDA approval -- -- $12 million senior secured converti ...